Amgen (AMGN) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $61.5 billion.
- Amgen's Non-Current Assets fell 203.79% to $61.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $247.4 billion, marking a year-over-year decrease of 320.53%. This contributed to the annual value of $61.5 billion for FY2025, which is 203.79% down from last year.
- According to the latest figures from Q4 2025, Amgen's Non-Current Assets is $61.5 billion, which was down 203.79% from $62.3 billion recorded in Q3 2025.
- Amgen's 5-year Non-Current Assets high stood at $66.8 billion for Q4 2023, and its period low was $39.6 billion during Q3 2022.
- Moreover, its 5-year median value for Non-Current Assets was $43.5 billion (2022), whereas its average is $51.3 billion.
- Its Non-Current Assets has fluctuated over the past 5 years, first soared by 5563.53% in 2023, then plummeted by 600.55% in 2024.
- Amgen's Non-Current Assets (Quarter) stood at $41.8 billion in 2021, then increased by 2.76% to $42.9 billion in 2022, then soared by 55.64% to $66.8 billion in 2023, then dropped by 6.01% to $62.8 billion in 2024, then fell by 2.04% to $61.5 billion in 2025.
- Its Non-Current Assets was $61.5 billion in Q4 2025, compared to $62.3 billion in Q3 2025 and $61.2 billion in Q2 2025.